Literature DB >> 20637497

Adult granulosa cell tumors of the ovary: tumor dissemination pattern at primary and recurrent situation, surgical outcome.

C Fotopoulou1, K Savvatis, E-I Braicu, V Brink-Spalink, S Darb-Esfahani, W Lichtenegger, J Sehouli.   

Abstract

OBJECTIVE: Granulosa-cell-tumors of the ovary (GCT) constitute a rare group of neoplasms with malignant potential. Due to the rarity of the disease intraoperative tumor-dissemination-patterns are not well defined and are mostly based on retrospective data. Aim of the present study was to describe surgical and clinical outcome and dissemination pathways in the primary and recurrent situation of the disease.
METHODS: All primary and relapsed GCT-patients, operated between 01/2001 and 02/2010 in our institution were evaluated using a systematic intraoperative documentation-tool (IMO). Surgical outcome, intraoperative tumor-dissemination-pattern and pathological and findings were separately analyzed for the primary and recurrent situation.
RESULTS: Overall, 45 patients were analyzed; including eighteen patients with primary and 27 patients with recurrent GCT. Tumor-dissemination-patterns differed significantly between primary and recurrent patients, by the latter having significantly higher rates of diffuse peritoneal involvement (15.8% vs. 52%; p=0.027) and of extraovarian tumor involvement of the middle (15.8% vs. 48.1%; p=0.05) and upper abdomen (0 vs. 33.3%; p=0.006). While all primary patients could be operated tumor-free, this was the case for 85.2% of the relapsed patients (p=0.13). A multivisceral operative approach with extensive peritonectomy, intestinal or diaphragmatic resection, splenectomy and partial hepatectomy/panceratectomy had to be performed only in recurrent GCT (55.6%).
CONCLUSIONS: Tumor-dissemination-pathways followed in primary and recurrent GCT differ significantly by higher rates of multivisceral tumor involvement in the recurrent situation of the disease. While at primary presentation extrapelvic involvement with peritoneal carcinosis appears only rare, surgical cytoreduction during relapse is more challenging involving a multivisceral approach.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20637497     DOI: 10.1016/j.ygyno.2010.06.031

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  11 in total

1.  Recurrent granulosa cell tumor presenting with spontaneous retroperitoneal hemorrhage: A case report.

Authors:  Sabino Zani; Maggie Stoecker; Mitchell W Cox; Angeles Alvarez Secord; Dan G Blazer
Journal:  Gynecol Oncol Case Rep       Date:  2011-09-14

2.  Prognostic predictors and spread patterns in adult ovarian granulosa cell tumors: a multicenter long-term follow-up study of 108 patients.

Authors:  Ibrahim Egemen Ertas; Kemal Gungorduk; Salih Taskin; Levent Akman; Aykut Ozdemir; Rifat Goklu; Mustafa Cosan Terek; Aydin Ozsaran; Yilmaz Dikmen; Yusuf Yildirim; Firat Ortac
Journal:  Int J Clin Oncol       Date:  2013-10-29       Impact factor: 3.402

3.  S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.

Authors:  U Wagner; P Harter; F Hilpert; S Mahner; A Reuß; A du Bois; E Petru; W Meier; P Ortner; K König; K Lindel; D Grab; P Piso; O Ortmann; I Runnebaum; J Pfisterer; D Lüftner; N Frickhofen; F Grünwald; B O Maier; J Diebold; S Hauptmann; F Kommoss; G Emons; B Radeleff; M Gebhardt; N Arnold; G Calaminus; I Weisse; J Weis; J Sehouli; D Fink; A Burges; A Hasenburg; C Eggert
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

Review 4.  Adult-type granulosa cell tumor of the ovary.

Authors:  Xiuwen Li; Bo Tian; Mengyan Liu; Chunlei Miao; Di Wang
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

5.  Betaglycan alters NFκB-TGFβ2 cross talk to reduce survival of human granulosa tumor cells.

Authors:  Maree Bilandzic; Simon Chu; Yao Wang; Han L Tan; Peter J Fuller; Jock K Findlay; Kaye L Stenvers
Journal:  Mol Endocrinol       Date:  2013-01-15

Review 6.  Recent advances in granulosa cell tumor ovary: a review.

Authors:  Vijaykumar Dehannathparambil Kottarathil; Michelle Aline Antony; Indu R Nair; Keechilat Pavithran
Journal:  Indian J Surg Oncol       Date:  2012-12-07

7.  Circulating levels of TNF-related apoptosis inducing-ligand are decreased in patients with large adult-type granulosa cell tumors-implications for therapeutic potential.

Authors:  Anniina Färkkilä; Giorgio Zauli; Ulla-Maija Haltia; Marjut Pihlajoki; Leila Unkila-Kallio; Paola Secchiero; Markku Heikinheimo
Journal:  Tumour Biol       Date:  2016-04-11

8.  Granulosa cell tumor of the ovary: time to launch a new prospective trial.

Authors:  Ga Won Yim; Young Tae Kim
Journal:  J Gynecol Oncol       Date:  2011-09-28       Impact factor: 4.401

9.  Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study.

Authors:  F Trillsch; S Mahner; E Vettorazzi; L Woelber; A Reuss; K Baumann; M-D Keyver-Paik; U Canzler; K Wollschlaeger; D Forner; J Pfisterer; W Schroeder; K Muenstedt; B Richter; C Fotopoulou; B Schmalfeldt; A Burges; N Ewald-Riegler; N de Gregorio; F Hilpert; T Fehm; W Meier; P Hillemanns; L Hanker; A Hasenburg; H-G Strauss; M Hellriegel; P Wimberger; S Kommoss; F Kommoss; S Hauptmann; A du Bois
Journal:  Br J Cancer       Date:  2015-01-06       Impact factor: 7.640

10.  Clinical Determinants Affecting Indications for Surgery and Chemotherapy in Recurrent Ovarian Granulosa Cell Tumor.

Authors:  Hidekatsu Nakai; Eiji Koike; Kosuke Murakami; Hisamitsu Takaya; Yasushi Kotani; Rika Nakai; Ayako Suzuki; Masato Aoki; Noriomi Matsumura; Masaki Mandai
Journal:  Healthcare (Basel)       Date:  2019-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.